Recent advances in sarcoidosis

Chest

Volumn 139, Issue 1, 2011, Pages 174-182

  Morgenthau, Adam S ^a   Iannuzzi, Michael C ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; CHEMOKINE RECEPTOR CCR2; CORTICOSTEROID; CYCLOOXYGENASE 2; GAMMA INTERFERON; GOLIMUMAB; HEAT SHOCK PROTEIN 70; HLA A2 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; INFLIXIMAB; INTERLEUKIN 2; INTERLEUKIN 8; KATG PROTEIN; MACROPHAGE ELASTASE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; PROSTACYCLIN; SILDENAFIL; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; USTEKINUMAB;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; ENDOBRONCHIAL ULTRASONOGRAPHY; GENE EXPRESSION; GENETIC ASSOCIATION; GRANULOMA; HUMAN; IMMUNITY; IMMUNOPATHOGENESIS; LOW DRUG DOSE; LUNG LAVAGE; LUNG SARCOIDOSIS; MACROPHAGE; MEDIASTINOSCOPY; MEDIASTINUM LYMPH NODE; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER T CELL; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSBRONCHIAL BIOPSY; TREATMENT OUTCOME;

EID: 78651430223     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-0188     Document Type: Article

References (73)

1. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/ WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis . 1999;16(2):149-173.
2. Marshall R, Smellie H, Baylis JH, Hoyle C, Bates DV . Pulmonary function in sarcoidosis. Thorax. 1958;13(1):48-58.
3. Sharma OP, Johnson R . Airway obstruction in sarcoidosis. A study of 123 nonsmoking black American patients with sarcoidosis. Chest. 1988;94(2):343-346.
4. Baughman RP, Teirstein AS, Judson MA, et al; Case Control Etiologic Study of Sarcoidosis (ACCESS) research group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164(10 pt 1):1885-1889.
5. Chen ES, Wahlström J, Song Z, et al. T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis. J Immunol. 2008;181(12):8784-8796.
6. Song Z, Marzilli L, Greenlee BM, et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med. 2005;201(5):755-767.
7. Teirstein AS, Machac J, Almeida O, Lu P, Padilla ML, Iannuzzi MC . Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest. 2007;132(6):1949-1953.
8. Newman LS, Rose CS, Bresnitz EA, et al; ACCESS Research Group . A case control etiologic study of sarcoidosis: environmental and occupational risk factors . Am J Respir Crit Care Med. 2004;170(12):1324-1330.
9. Peros-Golubicić T, Ljubić S. Cigarette smoking and sarcoidosis. Acta Med Croatica. 1995;49(4-5):187-193.
10. Valeyre D, Soler P, Clerici C, et al. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax. 1988;43(7):516-524.
11. Izbicki G, Chavko R, Banauch GI, et al; World Trade Center. World Trade Center "sarcoid-like" granulomatous pulmonary disease in New York City Fire Department rescue workers. Chest. 2007;131(5):1414-1423.
12. Rybicki BA, Iannuzzi MC, Frederick MM, et al; ACCESS Research Group. Familial aggregation of sarcoidosis. A casecontrol etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med. 2001;164(11):2085-2091.
13. Chen ES, Moller DR. Etiology of sarcoidosis. Clin Chest Med. 2008;29(3):365-377.
14. Grunewald J. Genetics of sarcoidosis. Curr Opin Pulm Med. 2008;14(5):434-439.
15. Rybicki BA, Kirkey KL, Major M, et al. Familial risk ratio of sarcoidosis in African-American sibs and parents. Am J Epidemiol. 2001;153(2):188-193. (Pubitemid 32060611)
16. Rybicki BA, Walewski JL, Maliarik MJ, Kian H, Iannuzzi MC; ACCESS Research Group. The BTNL2 gene and sarcoidosis susceptibility in African Americans and whites. Am J Hum Genet. 2005;77(3):491-499. (Pubitemid 41192655)
17. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411(6837):599-603.
18. Miceli-Richard C, Lesage S, Rybojad M, et al. CARD15 mutations in Blau syndrome. Nat Genet. 2001;29(1):19-20.
19. Schürmann M, Valentonyte R, Hampe J, Müller-Quernheim J, Schwinger E, Schreiber S. CARD15 gene mutations in sarcoidosis. Eur Respir J. 2003;22(5):748-754.
20. Milman N, Nielsen OH, Hviid TV, Fenger K. CARD15 single nucleotide polymorphisms 8, 12 and 13 are not increased in ethnic Danes with sarcoidosis. Respiration. 2007;74(1):76-79. (Pubitemid 46012451)
21. Hofmann S, Franke A, Fischer A, et al. Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis. Nat Genet. 2008;40(9):1103-1106.
22. Schürmann M, Lympany PA, Reichel P, et al. Familial sarcoidosis is linked to the major histocompatibility complex region. Am J Respir Crit Care Med. 2000;162(3 pt 1):861-864.
23. Hedfors E, Lindström F. HLA-B8/DR3 in sarcoidosis. Correlation to acute onset disease with arthritis. Tissue Antigens. 1983;22(3):200-203. (Pubitemid 13048491)
24. Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med. 1997;156(5):1601-1605. (Pubitemid 27505531)
25. Voorter CE, Drent M, van den Berg-Loonen EM. Severe pulmonary sarcoidosis is strongly associated with the haplotype HLA-DQB1*0602- DRB1*150101. Hum Immunol. 2005;66(7):826-835. (Pubitemid 41169773)
26. Moller DR, Konishi K, Kirby M, Balbi B, Crystal RG. Bias toward use of a specific T cell receptor beta-chain variable region in a subgroup of individuals with sarcoidosis. J Clin Invest. 1988;82(4):1183-1191.
27. Grunewald J, Eklund A. Role of CD4 1 T cells in sarcoidosis. Proc Am Thorac Soc. 2007;4(5):461-464.
28. Grunewald J, Eklund A. Löfgren's syndrome: human leukocyte antigen strongly influences the disease course. Am J Respir Crit Care Med. 2009;179(4):307-312.
29. Iannuzzi MC, Maliarik MJ, Poisson LM, Rybicki BA. Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans. Am J Respir Crit Care Med. 2003;167(9):1225-1231. (Pubitemid 36555094)
30. Ho LP, Urban BC, Thickett DR, Davies RJ, McMichael AJ . Deficiency of a subset of T-cells with immunoregulatory properties in sarcoidosis. Lancet. 2005;365(9464):1062-1072.
31. Kobayashi S, Kaneko Y, Seino K, et al. Impaired IFN-gamma production of Valpha24 NKT cells in non-remitting sarcoidosis. Int Immunol. 2004;16(2):215-222.
32. Powrie F. T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity. 1995;3(2):171-174.
33. Brunkow ME, Jeffery EW, Hjerrild KA, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse . Nat Genet. 2001;27(1):68-73.
34. Grunewald J, Olerup O, Persson U, Ohrn MB, Wigzell H, Eklund A. T-cell receptor variable region gene usage by CD4+ and CD8+ T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients. Proc Natl Acad Sci U S A. 1994;91(11):4965-4969.
35. Jonth AC, Silveira L, Fingerlin TE, et al; ACCESS Group. TGF-beta 1 variants in chronic beryllium disease and sarcoidosis. J Immunol. 2007;179(6):4255-4262.
36. Cui A, Anhenn O, Theegarten D; et al. Angiogenic and angiostatic chemokines in idiopathic pulmonary fibrosis and granulomatous lung disease. Respiration. 2009.
37. Kruit A, Grutters JC, Ruven HJ, et al. Transforming growth factor-beta gene polymorphisms in sarcoidosis patients with and without fibrosis. Chest. 2006;129(6):1584-1591.
38. Wijnen PA, Nelemans PJ, Verschakele JA, et al. The role of tumor necrosis factor alpha G-308A polymorphisms in the course of pulmonary sarcoidosis. Tissue Antigens. 2010;75(3):262-268.
39. Spagnolo P, Renzoni EA, Wells AU, et al. C-C chemokine receptor 2 and sarcoidosis: association with Lofgren's syndrome. Am J Respir Crit Care Med. 2003;168(10):1162-1166.
40. Crouser ED, Culver DA, Knox KS, et al. Gene expression profiling identifies MMP-12 and ADAMDEC1 as potential pathogenic mediators of pulmonary sarcoidosis. Am J Respir Crit Care Med. 2009;179(10):929-938.
41. Pabst S, Karpushova A, Diaz-Lacava A, et al. VEGF gene haplotypes are associated with sarcoidosis. Chest. 2010;137(1):156-163.
42. McDougal KE, Fallin MD, Moller DR, et al; ACCESS Research Group. Variation in the lymphotoxin-alpha/tumor necrosis factor locus modifies risk of erythema nodosum in sarcoidosis. J Invest Dermatol. 2009;129(8):1921-1926.
43. Pabst S, Baumgarten G, Stremmel A, et al. Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis. Clin Exp Immunol. 2006;143(3):420-426.
44. Spagnolo P, Sato H, Marshall SE, et al. Association between heat shock protein 70/Hom genetic polymorphisms and uveitis in patients with sarcoidosis. Invest Ophthalmol Vis Sci. 2007;48(7):3019-3025.
45. Rosenbaum JT, Pasadhika S, Crouser ED, et al. Hypothesis: sarcoidosis is a STAT1-mediated disease. Clin Immunol. 2009;132(2):174-183.
46. Idali F, Wahlström J, Dahlberg B, et al. Altered expression of T cell immunoglobulin-mucin (TIM) molecules in bronchoalveolar lavage CD4+ T cells in sarcoidosis. Respir Res. 2009;10:42.
47. Campo I, Morbini P, Zorzetto M, et al. Expression of receptor for advanced glycation end products in sarcoid granulomas. Am J Respir Crit Care Med. 2007;175(5):498-506.
48. Rastogi R, Du W, Ju D, et al. Dysregulation of p38 and MKP-1 in response to NOD1/TLR4 stimulation in sarcoid bronchoalveolar cells. Am J Respir Crit Care Med. In press. doi:10.1164/rccm.201005-0792OC.
49. Morbini P, Villa C, Campo I, Zorzetto M, Inghilleri S, Luisetti M. The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? Mod Pathol. 2006;19(11):1437-1445.
50. Hill MR, Papafili A, Booth H, et al. Functional prostaglandinendoperoxide synthase 2 polymorphism predicts poor out come in sarcoidosis. Am J Respir Crit Care Med. 2006;174(8):915-922.
51. Petkova DK, Clelland CA, Ronan JE, Lewis S, Knox AJ. Reduced expression of cyclooxygenase (COX) in idiopathic pulmonary fibrosis and sarcoidosis. Histopathology. 2003;43(4):381-386.
52. Boots AW, Drent M, Swennen EL, Moonen HJ, Bast A, Haenen GR. Antioxidant status associated with inflammation in sarcoidosis: a potential role for antioxidants. Respir Med. 2009;103(3):364-372.
53. Bargagli E, Bianchi N, Margollicci M, et al. Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis severity. Scand J Clin Lab Invest. 2008;68(6):479-483.
54. Grutters JC, Fellrath JM, Mulder L, Janssen R, van den Bosch JM, van Velzen-Blad H. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation. Chest. 2003;124(1):186-195.
55. Tremblay A, Stather DR, Maceachern P, Khalil M, Field SK. A randomized controlled trial of standard vs endobronchial ultrasonography-guided transbronchial needle aspiration in patients with suspected sarcoidosis. Chest. 2009;136(2):340-346.
56. Ardehali H, Howard DL, Hariri A, et al . A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy. Am Heart J. 2005;150(3):459-463.
57. 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging. 2008;35(5):933-941.
58. Kaminaga T, Takeshita T, Yamauchi T, Kawamura H, Yasuda M. The role of iodine-123-labeled 15-(p-iodophenyl)-3R, S-methylpentadecanoic acid scintigraphy in the detection of local myocardial involvement of sarcoidosis. Int J Cardiol. 2004;94(1):99-103.
59. 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J. 2005;26(15):1538- 1543.
60. Tadamura E, Yamamuro M, Kubo S, et al. Images in cardiovascular medicine. Multimodality imaging of cardiac sarcoidosis before and after steroid therapy. Circulation. 2006;113(20):e771-e773.
61. Utz JP, Limper AH, Kalra S, et al. Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest. 2003;124(1):177-185. (Pubitemid 36851350)
62. Baughman RP, Lower EE, Bradley DA, Raymond LA, Kaufman A. Etanercept for refractory ocular sarcoidosis: results of a doubleblind randomized trial. Chest. 2005;128(2):1062-1067.
63. Baughman RP, Drent M, Kavuru M, et al; Sarcoidosis Investigators. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med. 2006;174(7):795-802.
64. Judson MA, Baughman RP, Costabel U, et al; Centocor T48 Sarcoidosis Investigators. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J. 2008;31(6):1189-1196.
65. Rossman MD, Newman LS, Baughman RP, et al. A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2006;23(3):201-208.
66. Stagaki E, Mountford WK, Lackland DT, Judson MA. The treatment of lupus pernio: results of 116 treatment courses in 54 patients. Chest. 2009;135(2):468-476.
67. Fisher KA, Serlin DM, Wilson KC, Walter RE, Berman JS, Farber HW. Sarcoidosis-associated pulmonary hypertension: outcome with long-term epoprostenol treatment. Chest. 2006;130(5):1481-1488.
68. Milman N, Burton CM, Iversen M, Videbaek R, Jensen CV, Carlsen J. Pulmonary hypertension in end-stage pulmonary sarcoidosis: therapeutic effect of sildenafil? J Heart Lung Transplant. 2008;27(3):329-334.
69. Barnett CF, Bonura EJ, Nathan SD, et al. Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience. Chest. 2009;135(6):1455-1461.
70. Neville E, Mills RG, Jash DK, Mackinnon DM, Carstairs LS, James DG. Sarcoidosis of the upper respiratory tract and its association with lupus pernio. Thorax . 1976;31(6):660-664.
71. Aubart FC, Ouayoun M, Brauner M, et al. Sinonasal involvement in sarcoidosis: a case-control study of 20 patients. Medicine (Baltimore). 2006;85(6):365-371.
72. Long CM, Smith TL, Loehrl TA, Komorowski RA, Toohill RJ. Sinonasal disease in patients with sarcoidosis. Am J Rhinol. 2001;15(3):211-215.
73. Kay DJ, Har-El G. The role of endoscopic sinus surgery in chronic sinonasal sarcoidosis. Am J Rhinol. 2001;15(4):249-254.